Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the great words .
YES AND CMGO IS ON YOUR NO TOXIC DEBT LIST, I REALLY LIKE THAT COMPANY AND ITS POTENTIAL= http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117417689
EXCELLENT BOARD, I DONT KNOW WHY ANYONE DIDNT THINK OF THIS A LONG TIME AGO
KEEP UP THE GOOD WORK!!
Awesome! I see it on the list. I appreciate your time and effort.
The Ghost Board in another announcement nominates Global Equity International (GEQU) to the list of not having toxic debt.
Announcement: The Ghost Board of Moderators nominates New Wave Holdings, Inc. (NWAV) to the nomination list of companies not having toxic debt.
Pls looks at NWAV and nominate for non-toxic finance
Welcome to the Board. Thanks for the mark.
Nice list and thanks for sharing my Friend.
Happy Trading Week
Pete
"NO" floorless toxic convertibles are;
Mass Megawatts Wind Power, Inc (MMMW)
Iteknik Holding Corporation (ITKH)
United American Petroleum (UAPC)
Friendly Energy Exploration (FEGR)
Valmie Resources, Inc. (VMRI)
Cardica, Inc. (CRDC)
Sunset Capital Assets, Inc. (SNST)
Players Network (the)(PNTV)
Boreal Water Collection, Inc. (BRWC)
Dakshidin Corp. (DKSC)
Gazprom Oao (OGZPY)
Global Gaming Network, Inc. (GBGM)
Kiwa-Bio-Tech Products Group (KWBT)
Pharmacyte Biotech, Inc. (PMCB)
Jns Holdings Corporation (JNSH)
Mmrglobal,Inc. (MMRF)
Fitbit, Inc. (FIT)
One World Holdings,Inc. (OWOO)
International Spirit and Beverage Group, Inc.(ISBG)
Stratasys, LTD (SSYS)
CMG Holdings Group, Inc. (CMGO)
Royale Energy,Inc. (ROYL)
On4 Communications, Inc. (ONCI)
Polaris International Holdings, Inc. (PIHN)
Discovery Minerals, LTD (DSCR)
Well Power,Inc. (WPWR)
Tungsten Corp. (TUNG)
Green Parts International, Inc.( GNPT)
Zalemark Holdings Co., Inc. (ZMRK)
Daniels Corporate Advisory Co, Inc. (DCAC)
Idglobal Corp. (IDGC)
National Energy Services, Inc. (NESV)
Ism International, Inc. (ISML)
Praxsyn Corporation (PXYN)
Cannabis Science. Inc. (CBIS)
India Ecommerce Corp. (IEEC)
Q Lotus Holdings Inc. (QLTS)
BOARD MARKED, IM #84 FOLLOWER
Stocks $PMCB, $GROC and $MMMW looks great.
GROC Security Details
Share Structure
Market Value1 $1,594,003 a/o Sep 25, 2015
Authorized Shares 750,000,000 a/o Mar 17, 2013
Outstanding Shares 127,520,259 a/o Sep 23, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 37,190,108 a/o Sep 23, 2015
Announcement: The Ghost Board of Moderators nominates Great Rock Development Corp. (GROC) to the nomination list of companies not having toxic debt.
$PMCB ~ PharmaCyte Biotech, Inc. due diligence report
$PMCB recent news/filings
## source: finance.yahoo.com
Mon, 28 Sep 2015 12:20:00 GMT ~ SHAREHOLDER UPDATE: PharmaCyte Biotech Starts the Path to Phase II Clinicals - Small Cap Street
[PR Newswire] - PharmaCyte Biotech, Inc. (PMCB) shares ended the week at $.0795 up 10.42%. Investors of PharmaCyte Biotech may want to use the following link to gain vital information. Get our due diligence report at the link below.
read full: http://finance.yahoo.com/news/shareholder-pharmacyte-biotech-starts-path-122000708.html
*********************************************************
Fri, 25 Sep 2015 14:04:07 GMT ~ PharmaCyte Biotech Hires Industry-Leading Firm to Assist with Investigational New Drug Application
[at noodls] - SILVER SPRING, MD, September 25, 2015 (GLOBE NEWSWIRE) - PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes ...
read full: http://www.noodls.com/view/37EF10B2962282DE1C06E4D090D73706F38F61C3
*********************************************************
Fri, 25 Sep 2015 13:25:00 GMT ~ PharmaCyte Biotech Hires Industry-Leading Firm to Assist With Investigational New Drug Application
[GlobeNewswire] - SILVER SPRING, Md., Sept. 25, 2015-- PharmaCyte Biotech, Inc., a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes announced today that it has contracted ...
read full: http://finance.yahoo.com/news/pharmacyte-biotech-hires-industry-leading-132500552.html
*********************************************************
Wed, 23 Sep 2015 18:45:10 GMT ~ PharmaCyte Biotech Discusses Pancreatic Cancer Treatment for Upcoming Phase 2b Human Clinical Trial
[at noodls] - SILVER SPRING, Md., Sept. 22, 2015 (GLOBE NEWSWIRE) - PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its ...
read full: http://www.noodls.com/view/A7808586B0F3061FD31DC458807C5394D0C12DC4
*********************************************************
Tue, 22 Sep 2015 14:42:27 GMT ~ PharmaCyte Biotech Discusses Pancreatic Cancer Treatment for Upcoming Phase 2b Human Clinical Trial
[GlobeNewswire] - SILVER SPRING, Md., Sept. 22, 2015-- PharmaCyte Biotech, Inc., a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation ...
read full: http://finance.yahoo.com/news/pharmacyte-biotech-discusses-pancreatic-cancer-144227759.html
*********************************************************
$PMCB charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$PMCB company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/PMCB/company-info
Ticker: $PMCB
OTC Market Place: OTCQB
CIK code: 0001157075
Company name: PharmaCyte Biotech, Inc.
Company website: http://http://www.PharmaCyte.com
Incorporated In: NV, USA
Business Description: PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as \"Cell-in-a-Box\" This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer and its symptoms, and diabetes are being developed. PharmaCyte Biotech's treatment for solid tumor cancers involves encapsulating modified live cells capable of converting the prodrug ifosfamide into its active or \"cancer-killing\" form. These encapsulated live cells are placed as close to the tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. Ifosfamide is then given intravenously at one third the normal dose to eliminate adverse side effects. When the ifosfamide comes in contact with the encapsulated live cells through the circulatory system, the activation of the drug takes place at or near the tumor. This \"targeted chemotherapy\" has proven remarkably effective and safe to use in past clinical trials. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of the Cannabis plant. It is examining ways to exploit the benefits of Cell-in-a-Box technology in optimizing the anticancer effectiveness of Cannabis, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. In addition to developing treatments for pancreatic and other cancers, PharmaCyte Biotech is developing a treatment for Type 1 diabetes and Type 2 insulin-dependent diabetes. PharmaCyte Biotech plans to encapsulate a human cell line which has been genetically engineered to produce, store and secrete insulin on demand at levels in proportion to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology.Less >>
$PMCB share structure
## source: otcmarkets.com
Market Value: $59,102,576 a/o Sep 25, 2015
Shares Outstanding: 743,428,629 a/o Aug 24, 2015
Float: 529,206,849 a/o Aug 26, 2014
Authorized Shares: 1,490,000,000 a/o Aug 26, 2014
Par Value: 0.0001
$PMCB extra dd links
Company name: PharmaCyte Biotech, Inc.
Company website: http://http://www.PharmaCyte.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PMCB+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PMCB+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PMCB+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/news - http://finance.yahoo.com/q/h?s=PMCB+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PMCB/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PMCB+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PMCB
DTCC (dtcc.com): http://search2.dtcc.com/?q=PharmaCyte+Biotech%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=PharmaCyte+Biotech%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=PharmaCyte+Biotech%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://http://www.PharmaCyte.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://http://www.PharmaCyte.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://http://www.PharmaCyte.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PMCB
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001157075&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PMCB&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PMCB
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PMCB+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PMCB+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PMCB
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PMCB
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PMCB+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PMCB/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PMCB+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PMCB.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PMCB
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PMCB
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PMCB
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PMCB:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PMCB
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PMCB
GOOD MORNING , ALL 09-28-2015
tell who story not partial. $100mil vs ?????